A new depression medication called Spravato, which has recently undergone clinical trials, is showing great promise at providing relief from symptoms of depression in just a few hours. Symptoms associated with depression can include persistent feelings of sadness, lack of interest in activities once enjoyed, and thoughts of suicide.

Spravato offers new hope for those enduring depression symptoms and offers visible results in treating depression symptoms within just a couple of hours, offering hope and relief for people struggling with depression.

Spravato works by targeting glutamate receptors in the brain, restoring balance, and reducing depressive symptoms. This is the first new depression medication to be introduced in over 30 years. As such, it's expected to be a game-changer for millions of depression sufferers who haven't experienced relief with other traditional treatment methods.

Clinical trials have been conducted to test the effectiveness of Spravato, and the results show that participants experienced relief from depression symptoms in as little as two hours after receiving the medication. This is a significant improvement when compared to traditional treatment methods for depression, which can take weeks or even months to take effect.

Prime Psychiatry considers the potential of Spravato to help our patients manage their depression in a way that works quickly and effectively. Currently, they are recommending this medication for those with treatment-resistant depression, as it has shown great promise in those types of patients.

This breakthrough in depression medication offers renewed hope for those who have given up on finding an effective treatment for their symptoms. With this new option available, they can now experience relief from their symptoms in just a few hours, offering the prospect of a better quality of life.

About Prime Psychiatry

Prime Psychiatry is committed to providing individualized care using evidence-based principles. We provide psychiatric evaluations, medication management, Transcranial Magnetic Stimulation (for treatment of depression), Spravato, telepsychiatry, addiction treatment, disability evaluations and individual/couples counseling. Our services are offered to children, adolescents, and adults from 11–65-years. Prime Psychiatry was founded by Dr Efosa Airuehia, who is quadruple board certified in General Psychiatry, Child and Adolescent Psychiatry, Addiction Medicine and Lifestyle Medicine.